Last edited by Zulkirisar
Saturday, August 8, 2020 | History

2 edition of Amiodarone in cardiac arrhythmias found in the catalog.

Amiodarone in cardiac arrhythmias

Amiodarone in cardiac arrhythmias

[proceedings of a symposium held at Guy"s Hospital, London, 27th October 1978] (International congress and symposium series - Royal Society of Medicine ; no. 16)

  • 32 Want to read
  • 8 Currently reading

Published by Grune and Stratton .
Written in English


The Physical Object
FormatUnknown Binding
ID Numbers
Open LibraryOL11313944M
ISBN 100808912291
ISBN 109780808912293

Catheter Ablation of Cardiac Arrhythmias E-book. by Shoei K. Stephen Huang and Mark A. Wood. out of 5 stars 4. Kindle $ $ 54 to rent $ to buy. Hardcover Electrophysiological Foundations of Cardiac Arrhythmias: A Bridge Between Basic Mechanisms and Clinical Electrophysiology. by Andrew L. Cardiac Arrhythmias John A Kastor,University of Maryland, Baltimore, Maryland, USA ine,amiodarone,b-adrenergicblockingagents,calciumchannelantagonistsand of sudden cardiac death due to a potentially fatal Cardiac Size: KB.

Amiodarone in the prevention and treatment of arrhythmia Article Literature Review in Current opinion in investigational drugs (London, England: ) 3(7) August with 45 Reads.   Abstract. Continuous ECG monitoring is a useful method to evaluate the efficacy of antiarrhythmic drugs. The aim of our study was to evaluate the effects of amiodarone ( mg day −1 for seven days and then mg day −1, five days a week, for 60 days) in 20 patients with chronic ischaemic heart disease ascertained by stress test, thallium myocardial scintigraphy and coronary Cited by: 1.

Amiodarone is an oral and injectable drug that is used to correct abnormal rhythms of the heart. (It is an antiarrhythmic medication.) Although amiodarone has many side effects, some of which are severe and potentially fatal, it has been successful in treating many arrhythmias when other antiarrhythmic drugs have failed. Amiodarone is considered a "broad spectrum" antiarrhythmic medication. Conversion to oral amiodarone after intravenous (IV) administration. Less than 1 week IV infusion: mg/day ; week IV infusion: mg/day ; Greater than 3 week IV infusion: mg/day; Pediatric. Drug Resistant Refractory Cardiac Arrhythmias (Off-label) Oral.


Share this book
You might also like
The way ahead

The way ahead

Healthy Active Living

Healthy Active Living

currency question

currency question

Pillage

Pillage

U.S.-Japan trade

U.S.-Japan trade

Foundations of Personal Fitness Teachers Wraparound Edition

Foundations of Personal Fitness Teachers Wraparound Edition

Accounting made simple

Accounting made simple

[Letter to] Friend Higginson

[Letter to] Friend Higginson

Creating a comprehensive information literacy plan

Creating a comprehensive information literacy plan

Men and mysteries of Wall Street

Men and mysteries of Wall Street

Worker rights in the global economy

Worker rights in the global economy

Fun & games for a smarter dog

Fun & games for a smarter dog

Any Sunday

Any Sunday

Pharmacy practice in group medical clinics.

Pharmacy practice in group medical clinics.

Amiodarone in cardiac arrhythmias Download PDF EPUB FB2

Amiodarone in Cardiac Arrhythmias (International congress and symposium series / Royal Society of Medicine) [W.T. Simpson] on *FREE* shipping on qualifying offers. Amiodarone in Cardiac Arrhythmias (International congress and symposium series / Royal Society of Medicine): W.T.

Simpson: : Books. Amiodarone in cardiac arrhythmias. London: Royal Society of Medicine ; New York: Grune & Stratton, (OCoLC) Material Type: Conference publication: Document Type: Book: All Authors / Contributors: A D S Caldwell; W T Simpson; Royal Society of.

It is used to help keep the heart beating normally in people with life-threatening heart rhythm disorders of the ventricles (the lower chambers of the heart that allow blood to flow out of the heart).

Amiodarone is used to treat ventricular tachycardia or ventricular fibrillation.5/ amiodarone with placebo that reported the incidence of supraven-tricular arrhythmia, atrial fibrillation, or atrial flutter as the primary end point. Data Extraction: Two investigators independently collected all data.

Discrepancies were resolved by consensus. Data Synthesis: After File Size: KB. apy. Monitor heart rate and rhythm throughout therapy; PR prolonga-tion,slightQRSwidening,T-waveamplitudereductionwithT-wavewid-eningandbifurcation,ongationmaybe associated with worsening of arrhythmias and should be monitored closely during IV therapy.

Report bradycardia or increase in arrhyth-File Size: KB. User Reviews for Amiodarone to treat Arrhythmia. Also known as: Pacerone, Nexterone. The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care/ Can be useful to control heart rate in patients with atrial fibrillation when other measures are unsuccessful or contraindicated.

Heart Rate Control. Cardioversion: 5 to 7 mg/kg IV over 30 to 60 minutes, then to g per day continuous IV or divided oral doses until 10 g total 1.

mg IV over 10 min, then to 1 mg/min 2. Within ACLS, amiodarone is used for its antiarrhythmic properties and is effective for the treatment of supraventricular arrhythmias and ventricular arrhythmias.

The mechanism of action for amiodarone’s antiarrhythmic properties remains unclear, but it continues to be the primary antiarrhythmic medication for the treatment of ventricular fibrillation and ventricular tachycardia within the cardiac arrest algorithm.

Amiodarone (pacerone & nexterone) is a medication formulated to improve heartbeat rhythm. Doctors prescribe the drug to patients with life-threatening ventricle-related heart rhythm disorders to ensure the heart beats normally.

The ventricles are the heart’s lower chambers that allow blood flow out from the heart. Amiodarone is an antiarrhythmic medication used to treat and prevent a number of types of irregular heartbeats.

This includes ventricular tachycardia (VT), ventricular fibrillation (VF), and wide complex tachycardia, as well as atrial fibrillation and paroxysmal supraventricular tachycardia. Evidence in cardiac arrest, however, is poor. It can be given by mouth, intravenously, or ncy category: AU: C, US: D (Evidence of risk).

Amiodarone is used worldwide to treat cardiac arrhythmias, as well as highly symptomatic cases of atrial fibrillation. With this expanded use, especially following its United States Food and Drug Administration approval, and its use as a long-term therapy in common practice, reports of cancers temporarily related to amiodarone have begun to by: 2.

Amiodarone is recommended for shock-refractory ventricular arrhythmia during resuscitation; however, it is unknown whether amiodarone is effective for preventing ventricular arrhythmia recurrence in out-of-hospital cardiac arrest (OHCA) survivors treated with targeted temperature management (TTM).Cited by: 1.

Amiodarone as an iodinated benzofuran derivative is a potent antiarrhythmic drug that is being used for the treatment of a wide variety of cardiac arrhythmias.

For the first time, the Russian physiologist, Gleb Von Anrep discovered the original precursor molecule of Amiodarone that was called : Fereshteh Mehraein.

Neonatal Cardiac Arrhythmias INTRODUCTION: Identification and treatment of arrhythmias in newborns is challenging and differs from older children, and the natural history of arrhythmias presenting in the neonatal period is often dramatically different.

METHODS OF DIAGNOSIS AND THERAPY: For management of arrhythmias, consult Cardiology team. Medication Classification.

Amiodarone is classified as an antiarrhythmic drug, meaning that it is used on patients who have heart arrhythmias especially atrial flutter, atrial fibrillation, and tachyarrhythmias.

The most common arrhythmia that we use this medication on. Amiodarone is very effective for the treatment of atrial arrhythmias, especially atrial fibrillation. In the CTAF study, amiodarone was more effective at maintaining sinus rhythm than sotalol or propafenone.

72 This was also echoed by findings from the SAFE-T trial, which compared amiodarone to sotalol or a. Amiodarone in the prevention and treatment of arrhythmia. Auer J(1), Berent R, Eber B. Author information: (1)2nd Medical Department, General Hospital Wels, Austria.

@ There is good evidence that amiodarone is effective against a variety of arrhythmias and that it may be superior to other drugs in some by: Amiodarone is an antidysrhythmic used to terminate reentrant atrial or ventricular arrhythmias and has been a recurrent part the Advanced Cardiac Life Support (ACLS) algorithms.

It undergoes hepatic metabolism through cytochrome oxidase systems to produce another pharmacologically active but less potent metabolite, desethylamiodarone. The Role of Intravenous Amiodarone in the Management of Cardiac Arrhythmias Annals of Internal Medicine; (4): Amiodarone: Reevaluation of an Old Drug.

be effective in children with cardiac arrhythmias'; amiodarone resulted in either complete control (60%) or clinical improvement (/').1 The oral dosage and plasma concentrations of amiodarone associated with arrhythmia suppression in children havenot beenpreviously reported.

The unwanted effects experienced by adults receiving treatment with Cited by:. Amiodarone is an iodinated benzofuran derivative that was synthesized and tested as an antianginal agent in the s but was later discovered to have antiarrhythmic properties.

Amiodarone is widely prescribed, largely due to its efficacy in the management of both supraventricular and ventricular arrhythmias. Amiodarone was initially developed in the early s as a treatment for angina pectoris, since it produces coronary vasodilation and decreases cardiac oxygen demand.

However, its pronounced antiarrhythmic effects redirected its use and amiodarone has become a widely used class III anti-arrhythmic drug.

Compared to other antiarrhythmic drugs, it is more effective in treating both Cited by: Inthe American Heart Association recommended amiodarone as the primary antiarrhythmic agent for persistent ventricular tachycardia or ventricular fibrillation.[10].